USB
48
-5
DE
42
-6
LOW
61
3
GOOG
61
2
DAL
59
2
SYK
39
2
NFLX
64
3
NUE
46
-5
EFX
47
4
MPC
33
-14
APD
60
-5
FLS
67
-2
AAPL
46
6
LH
53
20
COST
54
6
STI
28
-7
BXP
57
3
LEN
61
6
RSG
64
4
APH
61
8
USB
48
-5
DE
42
-6
LOW
61
3
GOOG
61
2
DAL
59
2
SYK
39
2
NFLX
64
3
NUE
46
-5
EFX
47
4
MPC
33
-14
APD
60
-5
FLS
67
-2
AAPL
46
6
LH
53
20
COST
54
6
STI
28
-7
BXP
57
3
LEN
61
6
RSG
64
4
APH
61
8
Financhill
Back

Avidity Biosciences Stock Predictions

Forget Bitcoin - This Is the Real Opportunity of 2024

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
24

RNA
Avidity Biosciences

Last Price:
46.32
Seasonality Move:
20.94%

7 Day Trial

ALL ACCESS PASS

$ 7

The Tech Disruption Wall Street Isn't Talking About...Yet

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.

Avidity Biosciences Stock Forecast

  • Over the next 52 weeks, Avidity Biosciences has on average historically risen by 124% based on the past 4 years of stock performance.
  • Avidity Biosciences has risen higher in 1 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 25%
  • Is Avidity Biosciences Stock Undervalued?
    The current Avidity Biosciences [RNA] share price is $46.30. The Score for RNA is 24, which is 52% below its historic median score of 50, and infers higher risk than normal.
  • RNA is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.

Will Avidity Biosciences Stock Go Up Next Year?

  • Over the next 52 weeks, Avidity Biosciences has on average historically risen by 124% based on the past 4 years of stock performance.

Avidity Biosciences Stock Rating

Sell
24
Avidity Biosciences (RNA) is a Sell

Is Avidity Biosciences overpriced?

  • Avidity Biosciences has risen higher in 1 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 25%

Avidity Biosciences Stock Price History

Is RNA stock going to rise?

  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RNA is experiencing slight buying pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
aviditybiosciences.com

52-Week Data

52-Week High:
49.41
52-Week Low:
4.83

Prediction Charts

Market Cap:
5.42B
Price in USD:
46.30
Volume:
661.09K
Beta:
0.91

Technical Analysis

SMA50:
43.74
SMA100:
40.29
SMA200:
29.38
52-Wk Change:
647.98%

Stock Predictions

  • Is Avidity Biosciences stock public?
    Yes, Avidity Biosciences is a publicly traded company.
  • What is the Avidity Biosciences stock quote today?
    The Avidity Biosciences stock price is 46.30 USD today.
  • How to buy Avidity Biosciences stock online?
    You can buy Avidity Biosciences shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Sep-19 45.57 45.68 46.08 45.06
Sep-20 45.85 44.45 46.09 44.05
Sep-23 44.00 43.50 44.51 43.13
Sep-24 44.30 43.96 44.67 42.77
Sep-25 44.00 45.95 46.54 43.44
Sep-26 46.27 42.17 46.94 41.01
Sep-27 42.39 42.33 43.18 41.58
Sep-30 42.12 45.93 46.35 42.00
Oct-1 45.66 48.54 48.63 45.16
Oct-2 48.37 47.12 49.41 46.56
Oct-3 47.43 47.05 48.72 46.27
Oct-4 48.00 47.30 48.61 47.08
Oct-7 46.80 43.98 47.06 43.94
Oct-8 44.08 46.30 47.54 43.92

Avidity Biosciences Earnings

Avidity Biosciences Earnings Report: Per Share Avidity Biosciences Earnings Q1 Q2 Q3 and Q4 last year and next year.

Avidity Biosciences Forecast Revenue Growth

Avidity Biosciences Stock Analysis: Historical quarterly revenues per share for Avidity Biosciences and historical quarterly revenue growth:

  • Analysts estimate an earnings decrease this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.15 per share, and a decrease next year of $0.20 per share.

* Avidity Biosciences stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.